10x Genomics, Inc. (FRA:1KJ)

Market Cap	1.93B
Revenue (ttm)	547.02M
Net Income (ttm)	-65.05M
Shares Out	n/a
EPS (ttm)	-0.53
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	268
Open	15.38
Previous Close	14.60
Day's Range	15.38 - 15.49
52-Week Range	6.12 - 17.44
Beta	n/a
RSI	58.23
Earnings Date	Feb 13, 2026

About 10x Genomics

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as ...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2012
• Employees: 1,306
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1KJ

Financial Performance

In 2024, 10x Genomics's revenue was $610.79 million, a decrease of -1.28% compared to the previous year's $618.73 million. Losses were -$182.63 million, -28.41% less than in 2023.

Financial numbers in USD